ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery: An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve)

Sunday, March 23, 2014

Submitted by

J. Rafael Sadaba

Source

Source Name: Journal of the American College of Cardiology

Source URL: http://www.ncbi.nlm.nih.gov/pubmed/24291272

Author(s)

Lindman BR, Pibarot P, Arnold SV, Suri RM, McAndrew TC, Maniar HS, Zajarias A, Kodali S, Kirtane AJ, Thourani VH, Tuzcu EM, Svensson LG, Waksman R, Smith CR, Leon MB

In this manuscript, the authors compare outcomes among patients from the PARTNER trial with diabetes who underwent surgical or transcatheter treatment. Among these patients with diabetes, 6-month and 1-year all cause mortality was lower in the transcatheter group compared with the surgical group. At 2 years this survival benefit was lost. Stroke rates were similar between surgical and transcatheter treated patients at 30 days and 1 year.